Preloader

PGT-A (Aneuploidy)

Genetic Compass for Healthy Generations

PGT-A enables the selection and transfer of healthy embryos by detecting numerical chromosomal abnormalities (aneuploidies) in the embryo. By ruling out aneuploidy conditions related to chromosome number, such as Down and Turner syndromes, it reduces the risk of miscarriage and increases healthy pregnancy rates.

Test Features:

Feature

Detail

Note: Even if PGT-A analysis has been performed, standard ultrasound evaluation and NIPT tests are strongly recommended during pregnancy.
Method

NGS (Next-Generation Sequencing)

Coverage

All chromosomes (24 Chromosomes)

Sample Requirement

PBS-filled* tube for Day 5 biopsy (trophectoderm)

Turnaround Time (TAT)

~ 10 days

* Please contact our center for sample submission requirements.

Quality

Nesiller Genetic uses PGT-A kits developed by Thermo Fisher Scientific, recognized internationally for their proven clinical reliability. Our laboratory processes are independently assessed each year through GENQA, one of the world’s leading external quality assessment (EQA) programs, ensuring compliance with international quality standards.

Advanced Technology for Greater Confidence

  • Most Accurate Embryo Selection:PGT-A (Aneuploidy)
    The healthiest embryo for transfer can be selected with greater precision, minimizing the risk of error.
  • Reduced Risk of Miscarriage:
    The risk of miscarriage and genetic syndromes is significantly reduced.
  • Improved Mosaicism Assessment:
    Using NGS technology, low- and high-level mosaicism can be differentiated with high accuracy. In accordance with PGDIS, ESHRE, and ASRM recommendations, this provides clinicians with detailed information to support embryo transfer prioritization and more informed clinical decision-making regarding mosaic embryos.
//
Our customer support team is here to answer your questions!